+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Preclinical Imaging Market - Global Forecast 2026-2032- Product Image
Preclinical Imaging Market - Global Forecast 2026-2032- Product Image
New

Preclinical Imaging Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 194 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 4968721
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The preclinical imaging market is evolving rapidly as organizations adapt to new technology platforms and integrated data workflows. Senior executives aiming to strengthen operational resilience and secure scientific advantage are driving strategic changes in procurement and research infrastructure.

Market Snapshot: Preclinical Imaging Market

The preclinical imaging market grew from USD 4.75 billion in 2025 to USD 5.31 billion in 2026 and is projected to reach USD 10.52 billion by 2032, demonstrating a CAGR of 12.02%. This notable growth reflects rising demand from pharmaceutical companies, biotechnology firms, contract research organizations, and academic groups. Core drivers include the need for more advanced visualization tools and reliable data sources to accelerate translational studies and therapeutic innovation. As the sector pivots toward integrated, data-centric research environments, stakeholders are enhancing their capabilities to support more predictive and streamlined development pipelines.

Scope & Segmentation

This report delivers a comprehensive analysis of the changing preclinical imaging landscape to inform high-stakes planning and procurement. Market segmentation provides insights relevant for all major industry participants:

  • Product Classes: Coverage extends to bioluminescent and fluorescent imaging reagents, MRI contrast agents, PET radioactive tracers, ultrasound contrast agents, X-ray CT agents, and specialized software spanning image analysis, data management, and validation services.
  • System Architectures: Focus on both integrated multimodal systems and specialized standalone imaging platforms, enabling flexible throughput and resolution adjustments to suit varied laboratory settings.
  • Imaging Modalities: Analysis includes magnetic particle imaging, MRI, micro-CT, optical imaging, PET, and SPECT, underscoring their roles in expanding research options and investigative depth.
  • Applications: Assessment encompasses cardiology, oncology, neurology, immunology, as well as inflammatory and infectious disease research, supporting robust endpoint definition, safety profiling, and mechanistic study in drug development.
  • End Users: Examination addresses the different requirements and procurement patterns of academic and research institutes, CROs, pharmaceutical companies, and biotechnology organizations.
  • Regional Coverage: The report evaluates distinctions between the Americas, Europe, Middle East & Africa, and Asia-Pacific, including regional funding climates, regulatory environments, and infrastructure priorities.

Key Takeaways for Decision-Makers

  • Integrated reagent, platform, and software frameworks are influencing procurement standards and enabling more streamlined, reliable research processes within organizations.
  • Technological convergence supports the combination of anatomical, functional, and molecular insights, facilitating more predictive and data-rich research outputs.
  • Laboratories are increasingly adopting scalable and flexible systems, which allow them to adjust investments according to changing scientific priorities and operational demands.
  • Maintaining operational resilience requires proactive diversification of suppliers alongside strategic supply chain planning to offset potential logistical and regulatory risks, especially in unpredictable environments.
  • Collaboration between vendors, contract research organizations, and academic entities is proving vital for the adoption of novel imaging modalities and the enhancement of translational outcomes.
  • Standardization in software integration and data formats is supporting better reproducibility and empowering confident, data-driven decision-making across diverse research initiatives.

Tariff Impact and Procurement Adaptation in 2025

Recent tariff adjustments have reshaped value chain management within the preclinical imaging sector. Laboratory leadership and institutional buyers are adjusting procurement policies to prioritize supplier agility, regional inventory management, and robust contracting strategies tailored for risk mitigation. In response, vendors are reinforcing local distribution and post-sale support networks to ensure uninterrupted access to specialized imaging reagents and maintain operational continuity despite evolving trade policies.

Methodology & Data Sources

This research leverages structured interviews with industry leaders, systematic literature reviews, regulatory assessments, and technical documentation. Primary and secondary data validation ensures the report accurately presents current and emerging trends in the preclinical imaging market.

Why This Report Matters

  • Enables high-level strategic planning by highlighting opportunities in procurement, technological adoption, and operational best practices as the market evolves.
  • Offers actionable insights into emerging segment dynamics, regional characteristics, and the influence of new partnership models on value creation in translational research.

Conclusion

Preclinical imaging stands at the center of translational research advancement. Organizations that prioritize integration, strengthen operational resilience, and embrace collaborative approaches will be best positioned to achieve scientific and operational goals as market requirements shift.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Preclinical Imaging Market, by Product
8.1. Reagents
8.1.1. Bioluminescent Imaging Reagents
8.1.2. Fluorescent Imaging Reagents
8.1.3. MRI Contrasting Reagents
8.1.4. PET Radioactive Tracers
8.1.5. Ultrasound Contrasting Reagents
8.1.6. X-ray CT Contrasting Reagents
8.2. Software & Services
9. Preclinical Imaging Market, by Type
9.1. Multimodal Systems
9.2. Standalone Imaging Systems
10. Preclinical Imaging Market, by Imaging Modality
10.1. Magnetic Particle Imaging
10.2. Magnetic Resonance Imaging
10.3. Micro-Computed Tomography
10.4. Optical Imaging
10.5. Positron Emission Tomography
10.6. Single-Photon Emission Computed Tomography
11. Preclinical Imaging Market, by Applications
11.1. Cardiology
11.2. Drug Development
11.3. Immunology & Inflammation
11.4. Infectious Diseases
11.5. Neurology
11.6. Oncology
12. Preclinical Imaging Market, by End Users
12.1. Academic & Research Institutes
12.2. Contract Research Organizations
12.3. Pharmaceutical & Biotechnology Companies
13. Preclinical Imaging Market, by Region
13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific
14. Preclinical Imaging Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Preclinical Imaging Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. United States Preclinical Imaging Market
17. China Preclinical Imaging Market
18. Competitive Landscape
18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. Advanced Molecular Vision, Inc.
18.6. Agilent Technologies, Inc.
18.7. Angstrom Advanced Inc.
18.8. Aspect Imaging Ltd.
18.9. AXT Pty Ltd
18.10. Berthold Technologies
18.11. Bruker Corporation
18.12. Cubresa, Inc.
18.13. Euro-BioImaging ERIC
18.14. FUJIFILM Holdings America Corporation
18.15. GE HealthCare Technologies Inc.
18.16. IVIM Technology Corp.
18.17. KUB Technologies, Inc.
18.18. LI-COR, Inc.
18.19. Mediso Ltd.
18.20. Milabs B.V.
18.21. Miltenyi Biotec GmbH
18.22. MR Solutions Ltd.
18.23. Peira bvba
18.24. PerkinElmer Inc.
18.25. Revvity, Inc.
18.26. Scitech Pty Ltd
18.27. Siemens AG
18.28. TriFoil Imaging
18.29. United Imaging Healthcare Co., Ltd.
List of Figures
FIGURE 1. GLOBAL PRECLINICAL IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL PRECLINICAL IMAGING MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL PRECLINICAL IMAGING MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA PRECLINICAL IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL PRECLINICAL IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENT IMAGING REAGENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENT IMAGING REAGENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENT IMAGING REAGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENT IMAGING REAGENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENT IMAGING REAGENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENT IMAGING REAGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY MRI CONTRASTING REAGENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY MRI CONTRASTING REAGENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY MRI CONTRASTING REAGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY PET RADIOACTIVE TRACERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY PET RADIOACTIVE TRACERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY PET RADIOACTIVE TRACERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY ULTRASOUND CONTRASTING REAGENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY ULTRASOUND CONTRASTING REAGENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY ULTRASOUND CONTRASTING REAGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY X-RAY CT CONTRASTING REAGENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY X-RAY CT CONTRASTING REAGENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY X-RAY CT CONTRASTING REAGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY SOFTWARE & SERVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY SOFTWARE & SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY MULTIMODAL SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY MULTIMODAL SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY MULTIMODAL SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY STANDALONE IMAGING SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY STANDALONE IMAGING SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY STANDALONE IMAGING SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY MAGNETIC PARTICLE IMAGING, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY MAGNETIC PARTICLE IMAGING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY MAGNETIC PARTICLE IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY MICRO-COMPUTED TOMOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY MICRO-COMPUTED TOMOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY MICRO-COMPUTED TOMOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY OPTICAL IMAGING, BY REGION, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY OPTICAL IMAGING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY OPTICAL IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY CARDIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY DRUG DEVELOPMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY DRUG DEVELOPMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY DRUG DEVELOPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY IMMUNOLOGY & INFLAMMATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY IMMUNOLOGY & INFLAMMATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY IMMUNOLOGY & INFLAMMATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY INFECTIOUS DISEASES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY NEUROLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 84. AMERICAS PRECLINICAL IMAGING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 85. AMERICAS PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 86. AMERICAS PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 87. AMERICAS PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 88. AMERICAS PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
TABLE 89. AMERICAS PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 90. AMERICAS PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 91. NORTH AMERICA PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 92. NORTH AMERICA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 93. NORTH AMERICA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 94. NORTH AMERICA PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 95. NORTH AMERICA PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
TABLE 96. NORTH AMERICA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 97. NORTH AMERICA PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 98. LATIN AMERICA PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 99. LATIN AMERICA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 100. LATIN AMERICA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 101. LATIN AMERICA PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 102. LATIN AMERICA PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
TABLE 103. LATIN AMERICA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 104. LATIN AMERICA PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL IMAGING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 112. EUROPE PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 113. EUROPE PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 114. EUROPE PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 115. EUROPE PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 116. EUROPE PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
TABLE 117. EUROPE PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 118. EUROPE PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 119. MIDDLE EAST PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 120. MIDDLE EAST PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 121. MIDDLE EAST PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 122. MIDDLE EAST PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 123. MIDDLE EAST PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
TABLE 124. MIDDLE EAST PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 125. MIDDLE EAST PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 126. AFRICA PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 127. AFRICA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 128. AFRICA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 129. AFRICA PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 130. AFRICA PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
TABLE 131. AFRICA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 132. AFRICA PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 133. ASIA-PACIFIC PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 134. ASIA-PACIFIC PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 135. ASIA-PACIFIC PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 136. ASIA-PACIFIC PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 137. ASIA-PACIFIC PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
TABLE 138. ASIA-PACIFIC PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 139. ASIA-PACIFIC PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 140. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 141. ASEAN PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 142. ASEAN PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 143. ASEAN PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 144. ASEAN PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 145. ASEAN PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
TABLE 146. ASEAN PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 147. ASEAN PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 148. GCC PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 149. GCC PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 150. GCC PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 151. GCC PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 152. GCC PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
TABLE 153. GCC PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 154. GCC PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 155. EUROPEAN UNION PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 156. EUROPEAN UNION PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 157. EUROPEAN UNION PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 158. EUROPEAN UNION PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 159. EUROPEAN UNION PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
TABLE 160. EUROPEAN UNION PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 161. EUROPEAN UNION PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 162. BRICS PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 163. BRICS PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 164. BRICS PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 165. BRICS PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 166. BRICS PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
TABLE 167. BRICS PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 168. BRICS PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 169. G7 PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 170. G7 PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 171. G7 PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 172. G7 PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 173. G7 PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
TABLE 174. G7 PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 175. G7 PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 176. NATO PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 177. NATO PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 178. NATO PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 179. NATO PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 180. NATO PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
TABLE 181. NATO PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 182. NATO PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 183. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 184. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 185. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 186. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 187. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 188. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
TABLE 189. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 190. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 191. CHINA PRECLINICAL IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 192. CHINA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 193. CHINA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 194. CHINA PRECLINICAL IMAGING MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 195. CHINA PRECLINICAL IMAGING MARKET SIZE, BY IMAGING MODALITY, 2018-2032 (USD MILLION)
TABLE 196. CHINA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 197. CHINA PRECLINICAL IMAGING MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Preclinical Imaging market report include:
  • Advanced Molecular Vision, Inc.
  • Agilent Technologies, Inc.
  • Angstrom Advanced Inc.
  • Aspect Imaging Ltd.
  • AXT Pty Ltd
  • Berthold Technologies
  • Bruker Corporation
  • Cubresa, Inc.
  • Euro-BioImaging ERIC
  • FUJIFILM Holdings America Corporation
  • GE HealthCare Technologies Inc.
  • IVIM Technology Corp.
  • KUB Technologies, Inc.
  • LI-COR, Inc.
  • Mediso Ltd.
  • Milabs B.V.
  • Miltenyi Biotec GmbH
  • MR Solutions Ltd.
  • Peira bvba
  • PerkinElmer Inc.
  • Revvity, Inc.
  • Scitech Pty Ltd
  • Siemens AG
  • TriFoil Imaging
  • United Imaging Healthcare Co., Ltd.

Table Information

Report AttributeDetails
No. of Pages194
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 5.31 Billion
Forecasted Market Value ( USD ) by 2032 $ 10.52 Billion
Compound Annual Growth Rate12.0%
Regions CoveredGlobal
No. of Companies Mentioned26

Related Topics

Related Reports

Preclinical Imaging Market Report 2025 - Product Image

Preclinical Imaging Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Preclinical Imaging Market Size, Share & Trends Analysis Report by Type (Modality, Reagents, and Service), Application (Drug Discovery & Development, Basic & Translational Research), End Use (Pharma and Biotech Companies), and Region with Growth Forecasts, 2025-2033 - Product Image

Preclinical Imaging Market Size, Share & Trends Analysis Report by Type (Modality, Reagents, and Service), Application (Drug Discovery & Development, Basic & Translational Research), End Use (Pharma and Biotech Companies), and Region with Growth Forecasts, 2025-2033

  • Report
  • 120 Pages
  • Global
From
Preclinical Brain Imaging Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Preclinical Brain Imaging Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Preclinical Imaging (In-VIVO) - Global Strategic Business Report - Product Image

Preclinical Imaging (In-VIVO) - Global Strategic Business Report

  • Report
  • 192 Pages
  • Global
From
Optical Preclinical Imaging Market Size and Share - Outlook Report, Forecast Trends and Growth Analysis (2025-2034) - Product Image

Optical Preclinical Imaging Market Size and Share - Outlook Report, Forecast Trends and Growth Analysis (2025-2034)

  • Report
  • 350 Pages
  • Global
From

About the Market

The Preclinical Imaging market is a subset of the Drug Discovery market, which focuses on the development of new drugs and treatments. Preclinical Imaging is the use of imaging technologies to study the effects of drugs on living organisms. This includes techniques such as Magnetic Resonance Imaging (MRI), Computed Tomography (CT), Ultrasound, and Positron Emission Tomography (PET). These technologies allow researchers to observe the effects of drugs on the body in real-time, providing valuable insights into the efficacy and safety of potential treatments. Preclinical Imaging is used to assess the safety and efficacy of drugs before they are tested in clinical trials. Some companies in the Preclinical Imaging market include Bruker, Siemens Healthineers, Canon Medical Systems, Philips Healthcare, and GE Healthcare. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.